GlassScriptPhysician profile
Kathy Howard
NPI 1154661296
$4,407.42
in general payments reported to CMS, 2019-2025
31 companies · $755 in 2025
The $755 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $568 · 2022: $1,162 · 2023: $860 · 2024: $1,063 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,390 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,390.42 |
| Education | $287.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $845.99 | 2021-2024 | Ova1 |
| Abbvie INC. | $567.54 | 2021-2025 | |
| Biogen, INC. | $528.05 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $462.18 | 2021-2025 | Veozah |
| Organon LLC | $232.33 | 2022-2025 | Nexplanon, Jada System |
| Sumitomo Pharma America, INC. | $223.88 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $215.35 | 2022-2025 | |
| Shield Therapeutics INC | $208.28 | 2024-2025 | |
| Novo Nordisk INC | $169.18 | 2021-2024 | Wegovy, Saxenda |
| Pfizer INC. | $137.93 | 2022-2024 | |
| Daiichi Sankyo INC. | $110.25 | 2021-2024 | Injectafer |
| Biohaven Pharmaceutical Holding Company LTD. | $97.48 | 2022 | |
| Millicent US INC | $95.91 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Myovant Sciences INC. | $63.26 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.59 | 2021-2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $44.50 | 2022-2024 | Prolia, Evenity |
| Baxter Healthcare | $35.74 | 2024 | Perclot |
| Exact Sciences Corporation | $35.28 | 2023-2025 | Cologuard Collection Kit |
| Channel Medsystems, INC. | $34.12 | 2023 | |
| Agile Therapeutics, INC. | $31.98 | 2021 | |
| Hologic Sales and Service, LLC | $30.77 | 2022-2025 | Aptima |
| Merck Sharp & Dohme LLC | $28.40 | 2021 | |
| Urovant Sciences INC | $22.98 | 2022 | |
| Coopersurgical, INC. | $22.88 | 2025 | Paragard T 380a |
| Averitas Pharma INC. | $21.36 | 2024 | Qutenza |
| Laborie Medical Technologies Corp. | $19.50 | 2021 | |
| Gynesonics, INC. | $15.36 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Radius Health, INC. | $14.03 | 2025 | Tymlos |
| Evofem Biosciences, INC. | $12.09 | 2022 | |
| Therapeuticsmd, INC. | $11.75 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathy Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.